We believe Perrigo is in fine financial health. At the end of 2024, the company had roughly $560 million in cash and equivalents with about $3.3 billion in long-term debt. Its balance sheet was in a ...

JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech ...

Reckitt Benckiser is selling a majority stake in its home-care business, home to Air Wick fresheners and Cillit Bang cleaning products, to Advent International in a deal that values the whole unit at ...

New emerging life sciences hubs are gaining ground amid the market shift.

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

What a bunch of babies!” That was my reaction when, as an ardent believer in technical analysis over narratives, meme stocks, and Federal Reserve mania, I read that market expectations for a Fed rate ...

Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

Bitmine Immersion Technologies (BMNR) is up more than 20% in afternoon trading after billionaire investor Peter Thiel ...

Shoppers aged 45 to 60 now make up 25% of total spend for the beauty category, favouring products that ‘balance benefits with ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...